At the time when George Beadle and Edward Tatum proposed the one gene--one enzyme paradigm ([@B9]), the key and lock mechanism of substrate recognition in enzymes was used to explain how proteins accelerate chemical reactions. In the early days of molecular biology, enzymes and other proteins were thus seen as highly specific monofunctional molecules. This theoretical framework has influenced our functional annotations in biological systems: once a role is assigned to a given protein, other functions at any level are usually overlooked ([@B79]). However, since the 1940s many different mechanisms of multifunctionality have been described.

Proteins with multiple functions can influence the evolution of organisms, as they contribute to complexity and robustness. For instance, in early forms of life and in organisms undergoing genome reduction, multifunctionality may increase the functional repertoire of a limited set of genes ([@B63]; [@B28]). In addition, multifunctional proteins may coordinate the crosstalk of dissimilar biological processes, which is specially relevant in organisms with large genomes and intricate metabolic and regulatory pathways ([@B29]; [@B51]). Thus, the presence of undetected multifunctionality is a confounding factor in functional association analyses based on guilt-by-association, genotype-phenotype maps, and homology prediction and annotation ([@B54]; [@B93]; [@B35]; [@B26]). Identification and understanding of protein multifunctionality is needed to grant a better understanding of living systems in health and disease. Indeed, multifunctional proteins are frequently determinants of virulence and disease (reviewed in [@B44]; [@B57], [@B60]; [@B32]), as we will emphasize.

Other genetic mechanisms that are also known to contribute to the overall functional diversity of living systems are not herein addressed, such as alternative promoters or splicing in transcription, overlapping ORFs, alternative UTRs in translation, or post-translational modifications ([@B7]; [@B22]; [@B62]; [@B27]; [@B78]). Here, we review alternative definitions of protein multifunctionality and provide examples of multifunctional proteins associated to human disease. We focus specifically on multifunctionality at the protein level.

Naming and Classifying Multiple Forms of Protein Multifunctionality {#S1}
===================================================================

To date, several non-mutually exclusive terms have been used to describe recurrent phenomena in which proteins perform two or more functions, notably pleiotropy, multidomain proteins, promiscuity, and moonlighting. Although the terms discussed here are widely used in the literature, there is an underlying lack of consensus in their usage, which may consequently hinder our understanding of the extent and biological significance of each of the different forms of protein multifunctionality. For instance, a single enzyme can be pleiotropic, multidomain, and show promiscuous and moonlighting activities ([Figure 1](#F1){ref-type="fig"}; [@B1]; [@B8]; [@B33]; [@B114]; [@B106]).

![Different forms of protein multifunctionality in Ure2p. The Ure2 protein from budding yeast is a peroxidase enzyme that can form prions and is directly involved in nitrogen-catabolite repression by binding to and sequestering phosphorylated transcription factors in the cytoplasm, such as Gln3. **(A)** Deletion of *URE2* results in numerous phenotypes and observable traits related to different cellular pathways, which makes Ure2 a pleiotropic protein; only representative phenotypes associated to *ure2*Δ are shown. **(B)** Ure2 is a multidomain protein composed of an unstructured prion domain in addition to two globular domains typical of glutathione S-transferases (GST-N and GST-C). **(C)** The enzymatic activity of Ure2 is highly promiscuous: *in vitro*, Ure2 catalyze reactions with diverse substrates, involving different reaction mechanisms, within a single active site. Three different substrates for the glutathione-peroxidase activity of Ure2 are shown (from left to right: cumene hydroperoxide, hydrogen peroxide, and tert-butyl hydroperoxide). **(D)** The catalytic and binding activities of Ure2 are independent from one another: mutants lacking the Gln3-regulatory activity maintain their catalytic activity and such protein moonlighting is not explained by gene fusion, alternative splicing, or differential proteolysis. Protein images were generated using structure data from Protein Data Bank entry 1GgY, or Raptor X-predicted structures from Uniprot accessions [P18494](P18494) and [P23202](P23202).](fcell-08-00451-g001){#F1}

The definition of multifunctionality fundamentally relies on the definition of protein function itself. Protein function is the potential activity with a given physiological role that a polypeptide with a single primary sequence can partake by interacting with other biomolecules or chemical compounds. Based on Gene Ontology (GO) annotations, protein multifunctionality may be described at different overlapping levels ([Figure 2](#F2){ref-type="fig"}). The GO Consortium describes the function of a gene or gene product using three attributes: molecular function, biological process, and cellular component ([@B5]).

![Different kinds of multifunctional proteins. Different kinds of multifunctional proteins may be described based on their "molecular" or "biological" functions. Examples are provided for three multifunctional proteins from *S. cerevisiae* (Aro1, Sod1, and Aco1); functional annotations (GO terms) are from the Saccharomyces Genome Database ([www.yeastgenome.org](http://www.yeastgenome.org)).](fcell-08-00451-g002){#F2}

[@B92] analyzed the genome-wide multifunctionality of proteins in yeast, fly, and humans. Between 20 and 26% of the characterized genes in these organisms are multifunctional proteins annotated in two or more significantly different GO biological process terms. A smaller percentage of proteins are annotated within two or more GO molecular function terms, but this observation can be partly explained by the fact that the number of annotations belonging to the molecular function classification is lower relative to the biological process class. Compared to other proteins in the restricted set of analyzed organisms, proteins annotated with more than one GO molecular function -- which may include pleiotropic, multidomain, promiscuous, and moonlighting proteins -- are typically longer in sequence, are frequently more broadly expressed, have more protein domains and higher fractions of disordered regions, and tend to be conserved and essential ([@B92]). Importantly, such multifunctional genes are more often involved in human disorders. These results highlight the convenience of a systematic classification of multifunctionality to uncover its prevalence, characteristics, and relevance in biological systems.

Diverse stimuli may trigger action of different functions of a multifunctional protein (reviewed in [@B54], [@B60]; [@B84]). Cellular conditions such as temperature, pH, concentration of metabolites, and presence or absence of ligands have been observed to regulate the functions of multitasking proteins. Differential expression, post-transcriptional modifications, intra- or extra-cellular localization, protein structural changes -- from flexibility of small regions to complete refolding of an entire domain -- and homo-or hetero oligomeric conformations are frequent molecular mechanisms of protein multifunctionality. Such mechanisms are not mutually exclusive; actually, they tend to take place concertedly in the occurrence and alternation of multiple functions.

Pleiotropy May Reflect Multifunctionality at Different Levels {#S2}
=============================================================

Pleiotropy refers to phenomena in which a single genetic factor contributes to different cellular, physiological, or organismic traits ([@B102]; [@B85]; [@B113]). In genetic analysis, pleiotropy is assessed by describing the effects of mutations in measurable phenotypic traits. For example, the complete deletion of the *URE2* gene in the budding yeast *Saccharomyces cerevisiae* results in abnormal autophagy, decreased resistance to several cellular stresses, decreased telomere length, and increased cell size, among other phenotypes ([Figure 1A](#F1){ref-type="fig"}). Likewise, mutations in Swc6, a chromatin-remodeling protein from *Arabidopsis thaliana*, result in different leaf, flower, and fruit morphologies ([@B73]).

The mutant phenotypes of a pleiotropic multifunctional protein may arise from the perturbation of a single molecular function that partakes in different biological processes, or multiple molecular functions, each with impact on a different biological process ([@B23]; [@B42]). A major challenge in genetics, cell biology, and biomedical research is to identify the molecular mechanisms underlying pleiotropy ([@B108]; [@B42]). For example, the multiple phenotypes observed in phenylketonuria -- behavioral and mental disorders along with specific physical traits -- result from the inactivation of a single catalytic activity in the phenylalanine hydroxylase enzyme (reviewed in [@B47]; [@B94]). Conversely, numerous non-enzymatic activities have been described for the pleiotropic enzyme glyceraldehyde-3-phosphate dehydrogenase, some involved in human pathologies including different types of cancer and Huntington's, Parkinson's, and Alzheimer's diseases (reviewed in [@B104]; [@B100]).

Multiple Protein Domains May Results in Manifold Functions {#S3}
==========================================================

A protein domain is a polypeptide fragment with independent evolutionary history, structure, or function ([@B24]). Multidomain proteins typically arise from gene fusion, whereby two protein fragments become linked together in a single open reading frame ([@B69]). For example, in *Escherichia coli*, hydroxyethylthiazole kinase and thiamine-phosphate synthase are expressed in different proteins. However, in *S. cerevisiae* both catalytic activities are present in a single multidomain protein whereby each domain performs one enzymatic function ([@B53]). The analysis of protein domain composition depends on the definition of domain and identification methods used, either based on protein-sequence comparison or structural properties ([@B24]). For instance, the two domains of Ure2 are sometimes considered as subdomains of a single protein domain ([Figure 1B](#F1){ref-type="fig"}), while the limits of each structural region vary frequently among protein databases. Importantly, not all multidomain proteins are multifunctional. The shikimate dehydrogenase from *E. coli* is a two-domain NAD(P)-oxidoreductase: while one domain binds the cofactor, the other couples with the substrate, in such a way that the two domains catalyze a single reaction in the aromatic amino-acid biosynthesis pathway ([@B80]).

An example of a multidomain protein involved in cardiovascular disease is the G-protein coupled receptor kinase 2 (GRK2, also known as beta-adrenergic receptor kinase). The role of GRK2 on the regulation of cardiac receptors is the result of successful coordination among the three protein domains that compose the enzyme: a regulator of G-protein signaling homology domain, a protein-kinase domain, and a pleckstrin-homology domain ([@B75], [@B74]). While the disruption of the kinase gene can be lethal in mice, GRK2 overexpression has been linked to several cardiovascular diseases in humans ([@B107]; [@B2]). Interestingly, the expression of the pleckstrin-homology domain in mice with GRK2 overexpression can revert the disease phenotype, and could therefore be used as a treatment strategy to improve compromised heart function ([@B2]).

Promiscuity Is (Or Is Not) True Protein Multifunctionality {#S4}
==========================================================

Protein "promiscuity" describes a wide variety of related phenomena, all of which describe multiple catalytic activities or binding to multiple molecules ([@B49]; [@B84]; [@B18], [@B19]). The meaning and implications of promiscuity will depend on who one asks ([@B18]). From the evolutionary and biochemistry perspective, promiscuity usually involves physiologically irrelevant activities, by means of either inefficient or fortuitous activities in non-natural cellular contexts ([@B66]; [@B19]). In other fields, however, promiscuity typically describes broad specificity or binding to multiple ligands, substrates, or other macromolecules with no consideration to the relevance of the activities ([@B18]). In the former scenario pertaining enzyme activity, promiscuity is not a form of molecular multifunctionality, while in the latter cases it actually is.

The use of the term promiscuity also depends on the type of activity being described: in non-enzymatic activities, promiscuity is used to describe binding to several different molecules in a single or multiple structural locations ([@B50]; [@B87]; [@B96]). For instance, thioredoxin from *E. coli* or human Ras proteins have been described as promiscuous hub proteins given their many protein-protein interactions. While thioredoxin interactions take place in the same protein interface, Ras interactions occur in different binding sites ([@B50]). For catalytic activities, promiscuity refers to a single active site -- although not necessarily within the exact same residues -- that either binds to a diverse set of substrates (substrate promiscuity or ambiguity) or catalyzes different chemical transformations (catalytic promiscuity) ([@B66]; [@B84]; [@B67]; [@B18], [@B19]). For example, yeast Ure2 has glutathione peroxidase activity on different hydroperoxide molecules *in vitro* ([@B8]) and it can also oxidize a wide variety of substrates through alternative reaction mechanisms ([@B114]; [Figure 1C](#F1){ref-type="fig"}).

The altered efficiency of enzymes catalyzing different substrates has been linked to health complications, for instance those having to do with perturbed metabolism of exogenous compounds. Such is the case of serum paraoxonase 1 (PON1), a glycoprotein with broad substrate specificity capable of hydrolyzing organophosphates, lactones, and aromatic esters ([@B20]). PON1 is involved in a variety of roles, from pesticide sensitivity to a protective role against atherosclerosis by hydrolyzing oxidized lipids and preventing their accumulation in artery walls. Frequent human polymorphic variants of PON1 show different catalytic efficiencies to alternative organophosphorus compounds and are related to different pesticide susceptibilities: while variant PON1~R192~ hydrolyzes paraoxon faster than PON1~Q192~, PON1~Q192~ hydrolyzes diazoxon, sarin, and soman faster than the other isozyme ([@B21]). The altered hydrolysis efficiency toward other lipidic compounds may also explain why the PON1~R192~ variant has been associated with cardiovascular disease ([@B6]; [@B20]).

Dysfunction of catalytic-promiscuous enzymes can also influence Alzheimer's disease and cancer incidence. The omega class gluthatione s-transferases GSTO1 and GSTO2 can carry out two different chemical reactions in the same active site: gluthatione-dependent thiol transfer and dehydroascorbate reduction ([@B12]). The functions of GSTO1 and GSTO2 confer their role in oxidative stress and xenobiotic detoxification; glutathionylation prevents proteins from being oxidized and dehydroascorbate reduction takes part on the recycling pathway of the antioxidant ascorbic acid ([@B12]; [@B68]). Altered function of these gluthatione transferases may underlie the physiological conditions of several diseases: a GSTO2 variant with low expression levels has been found to be associated with an increased risk of Alzheimer disease at older age, while increased GSTO1 levels have been linked to a number of cancers such as pancreatic, esophageal, colorectal, and ovarian cancer, among others ([@B3]; [@B12]).

Moonlighting Proteins Multitask in Disparate Functions {#S5}
======================================================

Protein "moonlighting" was first defined as the phenomenon whereby a polypeptide performs two or more molecular functions that are not the result of gene fusion, splice variants, or multiple proteolytic fragments ([@B54]). "Gene sharing" was originally coined to refer to the phenomena where a gene specialized in a function performed alternative biological roles. While this term is sometimes used as a protein-moonlighting synonym, both phenomena may actually differ in their mechanisms and implications ([@B17]). The concept of moonlighting protein has continued to expand in a less restrictive definition, and is nowadays also used to name proteins showing unrelated roles in the organisms, irrespective of their evolutionary history ([@B14]; [@B61]; [@B65]).

The molecular activities of a moonlighting protein are usually described as unrelated to each other and independently of the primary sequence ([@B48]; [@B29]). Indeed, experimental evidence for the characterization of a moonlighting protein is mostly provided by mutants that are defective in one molecular function without affecting the others ([@B55]; [@B34]; [@B26]). In the case of yeast Ure2, mutants without nitrogen-catabolite repression activity maintain their enzymatic capacities ([Figure 1D](#F1){ref-type="fig"}). One of the first examples of a moonlighting protein was quite astonishing: the delta-crystallin of birds and reptiles is the exact same polypeptide as the argininosuccinate lyase enzyme; with its molecular function depending on the expression level and cellular context ([@B90]; [@B89]). In the lens, the protein is expressed at a high level and has a structural role, while in other tissues it is expressed at lower quantities and has an enzymatic function.

Moonlighting proteins with different molecular and functional characteristics have been described in a wide variety of organisms and the number of examples has increased in the last few years to almost 700 carefully curated moonlighting proteins ([@B46]; [@B76]; [@B15]; [@B31]). Even though experimental setups have been aimed at revealing protein moonlighting in an unbiased manner ([@B103]; [@B26]), still most known cases have been described by serendipity, either by studying a single protein in an exhaustive manner (e.g., the delta-crystalline [@B89]) or as rather surprising results from functional screens ([@B112]; [@B39]; [@B16]; [@B97]; [@B95]; [@B13]).

Computational strategies have been developed to characterize moonlighting proteins and to identify novel candidates for further experimental confirmation. Alignment algorithms evaluating similarity to other proteins, functional domains, or motifs have been tested to predict the nature of alternative functions within a protein ([@B36]). Protein-protein interaction databases can also reveal potential cases of protein moonlighting and provide suggestions to further test multifunctionality ([@B37]). The topological properties of a protein-protein interaction network and GO annotations were used to identify proteins exhibiting signs of so-called "extreme multifunctionality" ([@B14]). Khan and Kihara developed a method based on machine learning of different "omic" data, such as expression profiles, phylogenetic profiles, protein-protein interactions, genetic interactions and gene ontology ([@B65]). More recently, a method based on text-mining was developed to identify moonlighting protein candidates within publications hinting at semantically different functions ([@B52]).

As the number of known moonlighting proteins has increased, efforts have been made to understand how these molecules evolve and to guide in looking for more such multifunctional biomolecules. One of the first observations was that moonlighting proteins are enriched in conserved, highly expressed, proteins; however, this could also represent a bias where highly expressed and conserved proteins are also more likely of being studied ([@B48]). In addition to their expression patterns, sequence and structural properties may be related to protein moonlighting. For example, it has been proposed that moonlighting proteins could be enriched in proteins with well-packed, independent structural domains with little evolutionary trade-offs between the functions. Disordered regions could also facilitate the accumulation of functional mutations and shifts between activities ([@B105]). Yet, a correlation between domain composition, disordered regions, and moonlighting has not been documented unambiguously ([@B45]; [@B4]; [@B14]). With regards to the interactions, candidate moonlighting proteins interact with more functionally diverse proteins and more connected to other moonlighting proteins ([@B64]; [@B14]). Importantly, moonlighting proteins tend to be involved in mechanisms of disease ([@B14]; [@B32]).

Diseases and pathologies related to moonlighting phenomena are being constantly described ([@B101]; [@B56]; [@B110]; [@B43]; [@B32]). It has been estimated that up to 78% of candidate moonlighting proteins are associated to a human disease, in contrast to a 17.9% disease association for proteins in general ([@B32]). Among the diseases with the highest representation among moonlighting candidate proteins are those related to cancer (27%), immune system (17%), and nervous system (14%). As moonlighting proteins can have unrelated functions, it is expected that dysfunction of one or more of the protein functions gives rise to complex phenotypes. So far, moonlighting candidates have been found to be enriched in proteins that are involved in more than one disease and associated to complex instead of monogenic diseases ([@B110]). These proteins are associated to phenotypically dissimilar diseases that share co-morbidity patterns, hinting this could result from the perturbation of different processes of a single moonlighting protein.

The essential enzyme glucose-6-phosphate isomerase (GPI) is an example of a moonlighting protein that has been linked to anemia and neurological pathologies due to its multifuncional nature. The dimeric form of GPI catalyzes the reversible conversion of fructose-6-phosphate to glucose-6-phosphate in glycolysis ([@B72]), while the monomeric proteins show a neurotrophic function, independently of catalytic activity, which promotes the survival of embryonic spinal neurons, skeletal motor neurons, and sensory neurons ([@B38]). Mutations in GPI cause a disorder known as GPI-deficiency, characterized by breakage of red blood cells (hemolytic anemia) due to impairment of glycolysis ([@B72]). Most forms of GPI-deficiency are associated to mutations affecting only the isoenzyme activity, but severe forms of the disease, including neurological pathologies -- muscular weakness and intellectual disability -- are associated to mutations speculated to prevent correct protein folding disrupting both its catalytic and neurotrophic functions ([@B71]).

Post-translational modifications involved in the modulation of moonlighting activities have been associated to the development of human disease. Phosphorylation, acetylation, and ubiquitination -- among other protein modifications -- affect the cellular localization and the binding affinity of proteins to other molecules ([@B58]; [@B111]). For example, the S-nitrosylation of the glyceraldehyde 3-phosphate dehydrogenase (G3PDH) protein promotes the shift from the catalytic function to a protein-binding function ([@B40]). In this non-catalytic activity, G3PDH binds to a E3-ubiquitin ligase, Siah1, which promotes enter to the nucleus, where this protein complex initiates apoptosis. This signaling cascade has been proposed to take part in the neurodegeneration observed in Parkinson's and Alzheimer's diseases. Importantly, inhibition of S-nitrosylation of G3PDH by the drug L-deprenyl prevents cell death in cerebellar granule neurons in mice and delays the progression of Parkinson's disease in humans ([@B86]; [@B41]).

Disease can also be triggered by a protein acquiring a novel activity due to a structural perturbation (mutation or conformational change), in which case the new function is known as "neomorphic moonlighting function" ([@B56]). For example, the beta-2-microglobulin acquires a new aggregation function besides its normal function in the major histocompatibility complex of presenting peptide antigens ([@B81]; [@B56]). In the context of diminished kidney function or patients in long-term dialysis, beta-2-microglobulin is accumulated in the blood. This condition favors the conformational change to the amyloid fiber form and further protein aggregation, which ultimately leads to the development of amyloidosis characterized by arthropathy, lytic bone lesions, and chronic kidney disease.

Moonlighting proteins are not relevant to disease only due to their malfunction in humans, but also due to their role in pathogenesis and interaction with a human host ([@B44]; [@B30]; [@B59]). Intracellular proteins of pathogenic bacteria with previously described roles as metabolic enzymes (G3PDH), chaperones (Hsp60), or elongation factors (EF-Tu) have been found to exert a secondary function on the surface of bacterial cells as adhesins binding directly to host cells or extracellular matrix to initiate the infection process ([@B4]; [@B59]; [@B70]). Moonlighting proteins can also influence virulence by providing antibiotic resistance to bacteria ([@B98]) and influencing nutrient uptake of the pathogen ([@B82]). Overall, 25% of known moonlighting proteins are classified as virulence factors and are found in some pathogens of interest such as *Staphylococcus aureus*, *Helicobacter pylori*, *Haemophilus influenza* and *Neisseria meningitides*, among others ([@B30]; [@B59]).

Toward a Systematic Description of Protein Multifunctionality {#S6}
=============================================================

Huge amounts of data are being produced from experimental and computational analysis in functional genomics and systems biology, making it urgent to unify definitions of protein multifunctionality in a more systematic manner. Recent advances in large-scale genetic and genetic-interaction screens ([@B11]; [@B77]; [@B26]), proteomics and protein-protein interaction databases ([@B37]; [@B10]; [@B14]; [@B109]), and metabolite screens ([@B99]; [@B91]), along with computational analyses of functional data ([@B24]; [@B83]; [@B92]) have huge potential to reveal patterns of protein multifunctionality in living systems.

In this context, we note that certain features are good descriptors of the types of protein multifunctionality. Structural similarity, biological relatedness, structural autonomy, and physiological relevance of the different functions of a single protein will certainly influence the evolutionary scenarios and outcomes involved in the gain and loss of multifunctionality. For example, the lesser the structural autonomy between the activities in a protein, one would expect evolution of more similar molecular functions or the appearance of stronger evolutionary trade-offs. Duplication and divergence of the gene copies of multifunctional proteins with evolutionary trade-offs could result in single monofunctional proteins ([@B88]; [@B25]). Unrelated biological functions may be more prone to evolve separately if they are antagonistic between each other. Therefore, it is possible that less structural autonomous functions would have more biological coherence. Functions with strong -- or relevant -- phenotypic effects will typically be subjected to strong selective pressures. Therefore, in proteins from mild to highly structurally dependent and relevant activities, one would expect co-evolution of functions. In contrast, those cases in which only one of the functions is under strong selection may be prone to mild or little structural autonomy, allowing mutations of the residues involved in the activity.

Pleiotropy, multi-domain proteins, promiscuity, and moonlighting are different biological phenomena related to protein multifunctionality. The description of different recurrent phenomena has been -- and will certainly continue to be -- useful to the understanding of protein multifunctionality. However, as often seen in biology, huge diversity in the mechanisms and related phenomena will most likely exist. Moreover, the terms and limits we assign to each phenomenon are also prone to evolve, thus developing a natural lack of consensus. Therefore, it is possible that an alternative, straightforward, annotation of protein multifunctionality may enable future endeavors to comprehend the diversity, extent, and significance of protein multifunctionality in a more systematic manner.
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